LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma

Caitlin B. Conboy, Jennifer A. Yonkus, Eee LN H. Buckarma, Dong Gi Mun, Nathan W. Werneburg, Ryan D. Watkins, Roberto Alva-Ruiz, Jennifer L. Tomlinson, Yi Guo, Juan Wang, Daniel O'Brien, Chantal E. McCabe, Erik Jessen, Rondell P. Graham, Rogier C. Buijsman, Diep Vu, Jos de Man, Sumera I. Ilyas, Mark J. Truty, Mitesh BoradAkhilesh Pandey, Gregory J. Gores, Rory L. Smoot

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences